Premium
beta‐2‐microglobulin expression in relation to amplification of oncogenes and prognosis in breast carcinoma
Author(s) -
TSUDA H.,
HIROHASHI S.,
HIGUCHI K.,
SHIMOSATO Y.
Publication year - 1990
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.1990.tb01552.x
Subject(s) - beta 2 microglobulin , breast carcinoma , gene duplication , carcinoma , beta (programming language) , oncology , immunohistochemistry , medicine , pathology , cancer research , biology , breast cancer , gene , cancer , genetics , computer science , programming language
In 165 cases of breast carcinoma, loss of beta‐2‐microglobulin (β2m) expression had no obvious association with amplification of the oncogenes c‐erbB‐2, hst‐1/int‐2 or c‐myc , or with long‐term survival of the patients.